recognised.' Women are affected much more than men by diseases of the immune system, particularly systemic lupus erythematosus (SLE),2 the prototype 'autoimmune' disease. Systemic lupus erythematosus is most prevalent in the childbearing years with a female:male sex incidence of 9:1. This female to male ratio is much reduced in prepubertal children and after the menopause. `13 Menstruation may be associated with adverse symptomatology in 60% of lupus patients4 and seems to be limited to the 10 days immediately before the start of bleeding. Increased joint pains, fevers, malaise, and behaviour disturbances may be noted. During pregnancy, and especially in the puerperium, 'flares' of the disease may also occur. 5 The use of conjugated symmetric oestrogens for birth control may also be associated with such 'flares',6 and it has been suggested that oral contraceptives may be associated with the development of such complications as chorea7 and thromboembolism in some subjects with autoimmune disorders, particularly in the subset of systemic lupus erythematosus with antiphospholipid antibodies.8 9 
